↓ Skip to main content

Simvastatin Suppresses Apoptosis in Vulnerable Atherosclerotic Plaques Through Regulating the Expression of p53, Bcl-2 and Bcl-xL

Overview of attention for article published in Cardiovascular Drugs and Therapy, October 2011
Altmetric Badge

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
19 Mendeley
Title
Simvastatin Suppresses Apoptosis in Vulnerable Atherosclerotic Plaques Through Regulating the Expression of p53, Bcl-2 and Bcl-xL
Published in
Cardiovascular Drugs and Therapy, October 2011
DOI 10.1007/s10557-011-6347-z
Pubmed ID
Authors

Weiwei Qin, Yonggang Lu, Chengyan Zhan, Tao Shen, Lin Dou, Yong Man, Shu Wang, Chuanshi Xiao, Yunfei Bian, Jian Li

Abstract

Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, has antioxidant and anti-inflammatory properties that are independent of lipid-lowering abilities. This experiment was carried out to explore the effects of simvastatin on apoptosis in vulnerable atherosclerotic plaques of apoE-deficient mice.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Netherlands 1 5%
Unknown 17 89%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 32%
Professor 3 16%
Other 2 11%
Student > Master 2 11%
Researcher 2 11%
Other 2 11%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Agricultural and Biological Sciences 5 26%
Immunology and Microbiology 1 5%
Biochemistry, Genetics and Molecular Biology 1 5%
Psychology 1 5%
Other 1 5%
Unknown 3 16%